Kemia's Series B Round

Kemia raised a round of funding on March 29, 2004.

Kemia discovers and develops new, oral small molecule medicines for well-validated, clinically significant targets. Kemia applies proprietary chemistries and medicinal chemistry experience to two larg…

Articles about Kemia's Series B Round: